Take this "1" and shove it!!!

Anonymous

Guest
For the full year, sales climbed 16 percent to $58.6 billion, with revenue from prescription drugs reaching $32.5 billion, up 7 percent on 2010. Net income for 2011 was $9.2 billion, which included charges of $1.9 billion, representing a decline of 7 percent. CEO Joseph Jimenez remarked that the company "achieved solid sales growth and strong operating leverage in the fourth quarter and for the year as a whole." - Quote this when speaking to HR about your year end reviews!!! Our fearless leader just said that we all did our jobs!